Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer

PURPOSE: To evaluate the tolerability of escalating doses of stereotactic body radiation therapy in the treatment of localized prostate cancer. PATIENTS AND METHODS: Eligible patients included those with Gleason score 2 to 6 with prostate-specific antigen (PSA) ≤ 20, Gleason score 7 with PSA ≤ 15, ≤...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Boike, Thomas P., Lotan, Yair, Cho, L. Chinsoo, Brindle, Jeffrey, DeRose, Paul, Xie, Xian-Jin, Yan, Jingsheng, Foster, Ryan, Pistenmaa, David, Perkins, Alida, Cooley, Susan, Timmerman, Robert
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3138546/
https://ncbi.nlm.nih.gov/pubmed/21464418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.4377
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares